You are here

Home > News > All Press Releases

Press Releases

X-Rays May Show The Way To Better Alzheimer's Drugs

X-Rays May Show The Way To Better Alzheimer's Drugs

27.12.1999
Disease, Drugs & Diagnostics
Weizmann Institute scientists have elucidated the means by which a plant substance blocks a key brain enzyme involved in Alzheimer's disease.  
Protein Teamwork Drives Damaged Cells To Self-Destruct

Protein Teamwork Drives Damaged Cells To Self-Destruct

12.12.1999
Disease, Drugs & Diagnostics
Researchers at the Weizmann Institute of Science have recently deciphered part of the cellular events underlying apoptosis -- programmed cell death. Their findings, published in Nature earlier this summer, provide important insights into cancer pathologies and their potential cures.    
Key Progress by Weizmann Scientists in the Race to Unravel Ribosomal Structure

Key Progress by Weizmann Scientists in the Race to Unravel Ribosomal Structure

07.12.1999
Biochemistry
A team of Weizmann Institute and Max-Planck Society scientists has determined the structure of the small ribosomal subunit at the highest resolution ever achieved, including the site where protein biosynthesis begins.  
Progress Reported in Developing Compounds That Mimic Insulin for the Treatment of Type II Diabetes

Progress Reported in Developing Compounds That Mimic Insulin for the Treatment of Type II Diabetes

24.11.1999
Disease, Drugs & Diagnostics
Diabetic patients suffer from a metabolic disorder in which the insulin hormone responsible for allowing the passage of energy rich nutrients from the bloodstream into the body's cells does not function properly or at all. Diabetes afflicts 15 million Americans, and 90 percent of these cases are classified as type II diabetes.  
New Molecule Boosts Stem Cell Survival

New Molecule Boosts Stem Cell Survival

01.08.1999
Disease, Drugs & Diagnostics
Weizmann Institute researchers have developed a molecule that allows blood stem cells - the body's most primitive, immature cells that originate in the bone marrow - to multiply without maturation in the test tube.   This achievement, described in the August issue of the journal Blood, may improve bone marrow transplantation, in which stem cells are infused into a patient to replace defective or malignant marrow. The study may also advance gene therapy research.
Solar Technology Breakthrough

Solar Technology Breakthrough

06.07.1999
Environment
An innovative solar power system was presented at the ISES congress. The system has been under development since 1996, within the framework of the US-Israel Science and Technology Foundation, by a consortium, which includes BOEING, ORMAT, and Rotem Industries in collaboration with the Weizmann Institute of Science. The initial technologies were developed within the solar consortium Consolar in the framework of MAGNET program of the Ministry of Industry and Trade.    
DNA Crystals Help Bacteria Respond to Stress

DNA Crystals Help Bacteria Respond to Stress

01.07.1999
Biochemistry
DNA becomes remarkably organized in bacteria that are subjected to various conditions of stress, Weizmann Institute scientists reported in the July 1 issue of Nature. The tightly packed structure promotes the ability of the cells to withstand extreme environmental assaults such as oxidating agents and starvation.
How the Nose Knows

How the Nose Knows

01.07.1999
Genetics
Whether sniffing flowers, fresh-baked bread or the fumes of a passing automobile, the human olfactory system is an amazing scent sleuth, capable of distinguishing between millions of different smells. Now Weizmann Institute scientists have revealed one of the secrets behind this impressive ability.
Measuring the Minuscule

Measuring the Minuscule

01.07.1999
Space & Physics
In an experiment described in the May 20 issue of Nature, Weizmann Institute scientists have succeeded -- for the first time -- in measuring an electronic charge one-fifth the charge of a single electron. This is the smallest electronic charge that has ever been measured.  
Weizmann Institute Scientists Develop a Potential Future Treatment for Myasthenia Gravis

Weizmann Institute Scientists Develop a Potential Future Treatment for Myasthenia Gravis

01.07.1999
Disease, Drugs & Diagnostics
Weizmann Institute researchers have developed an effective treatment, administered through the nose, for a myasthenia gravis-like disease in rats, according to a report in the July 6 issue of the Proceedings of the National Academy of Sciences (PNAS).

Pages

 

Are you a journalist? Please sign up here for our press releases

 

Most Popular Articles

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Let it Rain

Added particles in the atmosphere could be affecting rainfall patterns

The Coin Toss Paradox

Can a game with “quantum” rules beat the odds?